Fi­bro­Gen, As­traZeneca ready Chi­na ap­pli­ca­tion as ane­mia drug scores in two piv­otal stud­ies

Fi­bro­gen $FGEN and As­traZeneca $AZN took a big step to­ward com­plet­ing their new drug ap­pli­ca­tion in Chi­na for the ane­mia drug rox­adu­s­tat af­ter hit­ting the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.